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 Sphingolipids are vital components of cellular mem-
branes that contribute to mechanical stability, signaling, 
and molecular sorting ( 1–3 ). Ceramides are obligatory 
precursors for sphingolipid biosynthesis, but also potent 
mediators of various stress responses, cell cycle arrest, and 
apoptosis ( 2, 4, 5 ). Consequently, cells should monitor 
sphingolipid biosynthesis closely to avoid jeopardizing their 
growth and viability. How this works is largely unexplored. 
Ceramides are synthesized on the cytosolic surface of the 
endoplasmic reticulum (ER) and transported by ceramide 
transfer protein (CERT) to the Golgi for conversion to SM 
( 6 ). SM production is catalyzed by a phosphatidylcholine 
(PC):ceramide choline phosphotransferase or SM synthase 
(SMS). Mammalian cells contain two SMS isoforms, namely, 
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we introduced a point mutation in the active site of SMSr, 
creating a catalytically inactive enzyme (SMSrD348E). To 
circumvent potential embryonic lethality, we generated a 
mouse line for conditional depletion of  smsr exon 6, en-
coding two catalytically essential residues. As SMSrD348E 
mice proved viable, we ubiquitously deleted exon 6 in 
these mice (SMSrdelEx6). Next, we analyzed the tissue dis-
tribution and abundance of CPE in wild-type, SMSrD348E, 
SMS2gt, and SMSrD348E×SMS2gt double mutant mice. 
We report on the consequences of disrupting SMSr- and 
SMS2-catalyzed CPE production on the lipid composition, 
cell survival, and integrity in a variety of mouse tissues. 
 MATERIAL AND METHODS 
 Generation of the SMSrD348E vector 
 In the fi rst step, fl anking regions of the 5 ′ and 3 ′ homologous 
regions (HRs) (5 ′ HR and 3 ′ HR) for homologous recombination 
in embryonic stem (ES) cells were amplifi ed via PCR and cloned 
into the pDTA-vector , which contained a MC1-diphtheria toxin A 
(DTA)-negative selection cassette ( 28 ). This vector then served as 
a retrieval vector in a gap repair cloning step on a bacterial artifi -
cial chromosome (#bMQ 369P09; Sanger Institute, UK) to insert 
the genomic sequence of exon 4 to exon 6 ( 29 ). The point muta-
tion D348E and insertion of the  MfeI restriction site in exon 5 of 
the  smsr gene and a part of the 3 ′ region of  smsr were generated 
by PCR mutagenesis, and the resulting fragment was cloned into 
the pBluescript vector. Between exon 6 and the untranslated re-
gion (UTR) of  smsr , a   -galactosidase gene  ( lacZ ) reporter gene 
with an internal ribosomal entry site was inserted into the vector 
mentioned above. In the next step we inserted the neomycin resis-
tance gene, driven by the Simian virus 40 promoter and fl anked by 
Flp recognition target  ( frt ) sites into the vector described above 
between exon 5 and 6 of the  smsr gene. To obtain the fi nal 
SMSrD348E vector, we combined both vectors via a gap repair 
cloning step, which resulted in a vector containing the DTA selec-
tion cassette followed by the genomic sequences of exon 4 to exon 
5 and the neomycin resistance gene downstream of exon 5 fol-
lowed by the D348E mutation in exon 6 and the nuclear localiza-
tion signal- lacz reporter gene with internal ribosomal entry site 
downstream of exon 6 and part of the 3 ′ UTR. The fi nal noncondi-
tional SMSrD348E vector was analyzed by restriction mapping and 
partial sequencing (GATC Biotech, Germany). The functionality 
of the  frt sites was tested by transformation of the targeting vector 
into Flp recombinase expressing  Escherichia coli bacteria ( 30 ). 
 Generation of the conditional SMSrdelEx6 vector 
 Using mutagenesis PCR with the previously mentioned bacte-
rial artificial chromosome (#bMQ 369P09; Sanger Institute) 
fl anking regions of the 5 ′ HR were generated and cloned into the 
vector ploxP-frt-dualneo-frt-loxP. The vector provides  loxP se-
quences for conditional deletion of exon 6 surrounding a Simian 
virus 40 promoter-driven neomycin resistance gene fl anked by  frt 
sites. Insertion took place upstream of the 5 ′ loxP site and the 
5 ′ HR was extended to its full size (a 4 kb part of intron 4) by gap 
repair cloning in the last step. In the next step, fl anking regions 
of an internal HR downstream of the 5 ′ loxP site (5 ′ fl anking re-
gion, part of exon 5; 3 ′ fl anking region, part of 3 ′ UTR) were pro-
duced by mutagenesis PCR. The region ranging from exon 5 to 
the 3 ′ UTR was completed in the second to last step by gap repair 
cloning. The 3 ′ HR representing the 1.8 kb 5 ′ region of the 3 ′ UTR 
was generated by PCR and cloned into the vector pMJ_SMSrbi-
sEx5-eGFP (containing the SMSr cDNA sequence up to exon 5 
SMS1 responsible for bulk production of SM in the Golgi 
lumen and SMS2 likely serving a role in regenerating SM 
from ceramides liberated by SM phosphodiesterases on the 
exoplasmic surface of the plasma membrane ( 7, 8 ). To-
gether with a closely related enzyme, SMS-related protein 
(SMSr), they form the SMS protein family ( 9 ). 
 Both SMS1 and SMS2 support cell growth, at least in 
certain types of cultured cancer cells ( 8, 10 ). Moreover, 
SMS1 depletion has been reported to enhance ceramide 
production and apoptosis after photodamage ( 11 ), while 
its contribution to the generation of plasma membrane-
associated SM is critical for Fas-clustering and Fas-mediated 
apoptosis ( 12 ). SMS1 defi ciency in mice causes moder-
ate neonatal lethality, reduced body weight, loss of fat 
tissue mass, and white adipose tissue function associated 
with impaired insulin secretion ( 13, 14 ). It also decreases 
SM and elevates glycosphingolipid levels in plasma, liver, 
and macrophages, and attenuates macrophage activa-
tion by NF  B and MAPK in response to infl ammatory 
stimuli ( 15 ). SMS2 defi ciency, on the other hand, amelio-
rates high fat-induced obesity ( 16, 17 ), attenuates lipo-
polysaccharide-induced lung injury ( 18 ), and reduces 
atherosclerosis ( 19 ). A recent study investigating SMS2 
defi ciency in the brain reported decreased expression and 
altered function of drug transporters ( 20 ). 
 Besides bulk amounts of SM, mammalian cells also pro-
duce small quantities of the SM analog, ceramide phospho-
ethanolamine (CPE) ( 21, 22 ), a widespread but largely 
unexplored sphingolipid. We recently demonstrated that 
SMS2 is, in fact, a bifunctional enzyme that produces both 
SM and CPE at the plasma membrane ( 23 ). The biological 
relevance of SMS2-catalyzed CPE production remains to be 
established. In addition, we found that SMSr functions as 
monofunctional CPE synthase in the ER ( 24 ). SMSr is the 
best-conserved member of the SMS protein family, with ho-
mologs in organisms such as  Drosophila , which lacks SM and 
synthesizes CPE as the principal sphingolipid. While 
 Drosophila SMSr exhibits CPE synthase activity ( 24 ), bulk 
production of CPE in this organism is mediated by an 
insect-specifi c enzyme that belongs to the CDP-alcohol 
phosphotransferase superfamily ( 25 ). Remarkably, acute 
disruption of SMSr catalytic activity in cultured mammalian 
and insect cells causes a substantial rise in ER ceramides, 
leading to a structural collapse of ER exit sites and fragmen-
tation of the Golgi complex ( 24 ). Subsequent work revealed 
that SMSr acts as a suppressor of ceramide-induced mito-
chondrial apoptosis in various human carcinoma cell lines, 
including HeLa ( 26 ). We also found that SMSr-catalyzed 
CPE production, although required, is not suffi cient to sup-
press ceramide-induced cell death and that SMSr-mediated 
control over ER ceramides is critically dependent on the 
enzyme’s  N -terminal sterile   motif (SAM) domain ( 26 ). 
Based on these results, we postulated a primary role of SMSr 
in monitoring ER ceramide levels to prevent inappropriate 
cell death during sphingolipid biosynthesis. 
 In the current study, we generated mouse lines lacking 
SMSr catalytic activity and crossbred these with SMS2-null 
mice ( 27 ) in order to investigate the impact of disrupting 
SMS-mediated CPE production in vivo. In one mouse line, 
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of wild-type heterozygous (+/SMSrD348E or +/SMSrdelEx6) 
and homozygous (SMSrD348E or SMSrdelEx6) mice. For the 
SMSrD348E mice, DNA was digested with  Bcl I and a 5 ′ external 
probe binding downstream of exon 1 and upstream of the 5 ′ HR 
was used. For analysis of SMSrdelEx6 mice, we used an internal 
probe binding in the 3 ′ HR and external  Xmn I restriction sites 
(upstream of the 5 ′ HR and downstream of the 3 ′ HR). 
 CPE-synthase assay 
 Brain and liver samples from 10-week-old mice were homoge-
nized in buffer R [20 mM HEPES-KOH (pH 7.2), 15 mM KCl, 
5 mM NaCl, 250 mM sucrose] including freshly added PMSF 
(200 × stock 34.8 mg/ml in isopropanol) and protease inhibitor 
cocktail (1,000 × stock in DMSO containing 1 mg/ml aprotinin, 
1 mg/ml leupeptin, 1 mg/ml pepstatin, 5 mg/ml antipain, 
157 mg/ml benzamidine) using a Precellys ® homogenizer (Peqlab 
Biotechnology, Germany). Microsomal fractions were obtained 
by centrifugation at 960  g for 10 min followed by centrifugation 
of the supernatant at 100,000  g for 1 h. The microsomal pellet 
was resuspended in buffer R, pressed 20 times through a 27 
gauge needle , aliquoted, frozen in liquid nitrogen, and stored at 
  70°C. Protein concentration was determined using the BCA assay 
kit (Sigma-Aldrich, USA). 
 Aliquots of microsomes were normalized to protein content 
and resuspended in 400   l end volume of ice-cold buffer R plus 
0.1% v/v of 1,000 × protease inhibitor cocktail and kept on ice in 
12 ml Pyrex tubes with lids.  N -ethylmaleimide was added to this 
suspension to a fi nal concentration of 0.5 mM from a 100 mM 
stock solution in ethanol. Then, C6 nitrobenzoxadiazole-
ceramide (NBD-Cer) [6-(( N -(7-nitrobenz-2-oxa-1,3-diazol-4-yl)
amino)hexanoyl) sphingosine; 2 mM stock in absolute ethanol; 
Molecular Probes] was added to a fi nal concentration of 2.5   M. 
Samples were kept on ice for 5–10 min to allow incorporation of 
the NBD-Cer probe into the membrane. After this, samples were 
shifted to 37°C with continuous shaking for 2 h. The reaction was 
stopped by addition of 1 ml methanol and 0.5 ml chloroform, 
and vigorous vortexing. After this, lipids were extracted and 
dried essentially as described by Ternes et al. ( 23 ). 
 For analysis, the dried lipid fi lm was redissolved in a suitable 
volume of chloroform:methanol (2:1 v/v) and applied to a TLC 
plate (NANO-ADAMANT #821150; Macherey-Nagel) using the 
CAMAG Linomat 5 (022.7808) operated at a dosage speed of 
120 nl/s from a 100   l syringe. TLC development was performed 
using the CAMAG ADC2 TLC developer, using the protocol 
essentially as described by Ternes et al. ( 23 ), which comprised two 
consecutive 1D-runs. The excess NBD-Cer was eluted in a fi rst 
run (acetone). Then the NBD-SM and NBD-CPE formed were 
separated using a second run in the same dimension, with basic 
eluent [chloroform:methanol:ammonia (aq) (50:25:6 v/v/v)]. 
 After thoroughly drying the TLC plate, NBD-lipid species were 
visualized by scanning on a Typhoon FLA 9500 imager (laser 
473 nm, fi lter setting BPB1, PMT 290 V) at a resolution of 50   m 
pixel size. Images were contrast-adjusted using the ImageQuant 
software and then exported to Tiff format for publication. 
 Construction of adenovirus expressing 
phosphatidylethanolamine  N -methyltransferase 
 To construct recombinant adenovirus, a cDNA encoding human 
phosphatidylethanolamine  N -methyltransferase (PEMT) was 
subcloned into a pADTrack-CMV shuttle vector, linearized with 
 Pme I, and inserted into an adenovirus using pADEasy-1 system for 
homologous recombination in  E. coli . This adenovirus (Ad.PEMT) 
expressed both PEMT and green fl uorescent protein (GFP). An 
adenovirus expressing only GFP (Ad.GFP) was used as a control. 
Male C57BL/6 (backcrossed more than seven generations) 
followed by an in-frame  egfp sequence) downstream of the  egfp 
sequence. From this vector, the resulting sequence consisting of 
the 3 ′ region of intron 4, exon 5,  egfp , and the 3 ′ HR was fi rst 
cloned into the pDTA vector harboring the MC1 -DTA-negative 
selection cassette ( 28 ). Then the sequence, together with the 
downstream DTA-cassette, was inserted downstream of the 3 ′  loxP 
site into the initially produced vector containing the 5 ′ HR. The 
targeting vector was fi nished by two independent gap repair clon-
ing steps as mentioned above. The SMSrD348E targeting vector 
identity was verifi ed by restriction mapping and partial sequenc-
ing. Functionality of the  loxP or  frt sites was proved by transforma-
tion of  E. coli bacteria expressing the  Cre or  Flp recombinase, 
respectively ( 30 ). The conditional SMSrdelEx6 vector allows the 
cell type- or time-specifi c expression of the generated mutation. 
In contrast, the mutation in SMSrD348E mice is already present 
in the zygote and hence in all descendent cells. 
 Screening of ES cell clones 
 For transfection of HM1 ES cells ( 31 ) via electroporation 
(0.8 kV, 3   F; Gene Pulser, Bio-Rad), 300   g of DNA of the corre-
sponding vector were linearized by  Not I digestion. Selection of 
transfected ES cells was carried out with 350   g/  l G418-neomycin 
(Invitrogen, Germany). Resulting ES cell clones were tested by 
Southern blot analyses for recombination at the 3 ′ HP and 5 ′ HR 
(external probes), as well as for single integration of the vector 
construct (internal probe; data not shown). The transfection of 
cells with the SMSrD348E vector yielded 22% stably transfected 
cell clones that carried the vector integrated by homologous 
recombination. Transfection with the SMSrdelEx6 vector yielded 
21.5% stably transfected cells. 
 Generation of SMSrD348E and SMSrdelEx6 mice 
 Homologously recombined ES cells were injected into C57BL/6 
mouse blastocysts ( 32 ). Blastocysts were used to generate germ-
line transmission chimeras. These chimeras were mated with 
C57BL/6 mice and the homologous recombination was verifi ed by 
PCR from tail tip DNA of the agouti-colored offspring. For the 
SMSrD348E mice, we used an exon-specifi c sense primer (SMSr_1, 
5 ′ -GAA ACT ACG ACG GGC ATT-3 ′ ) together with an intron-
specifi c antisense primer (SMSr_3b, 5 ′ -TTC AGC TCT GTC TCA 
TGT GGC-3 ′ ) and a neomycin cassette-specifi c antisense primer 
(SMSr_2b, 5 ′ -CCT TCC GTG TTT CAG TTA GCC-3 ′ ). 
 For the SMSrdelEx6 mice, we used an intron-specifi c sense 
primer (SMSr_loxP_for 5 ′ -AGC TCT GGT AAT TCT CTG GGC-
3 ′ ) combined with an eGFP-specifi c antisense primer (SMSr_
eGFP_rev, 5 ′ -AAG TCG TGC TGC TTC ATG TGG-3 ′ ) and an 
intron-specifi c antisense primer (SMSr_loxP_rev, 5 ′ -TCT CAC 
TTC CTC CCT AGT TCC-3 ′ ). For both mouse lines the progeny 
were mated with Flp recombinase-expressing mice ( 33 ) to remove 
the neomycin resistance cassette and bred with C57BL/6 mice to 
reach a genetic background of at least 87.5% C57BL/6. For the 
conditional SMSrdelEx6 mouse line, the initially generated 
“fl oxed” animals were bred with mice expressing the Cre recombi-
nase under control of the phosphoglycerate kinase  ( pgk ) promoter 
( 34 ) for ubiquitous deletion of exon 6. Animals were kept under 
standard conditions with a 12 h dark to light cycle with food and 
water ad libitum. All housing and experimental conditions were in 
accordance to instructions of local and state authorities. Prior to 
dissection, animals were anesthetized with Florene ® (AbbVie, Ger-
many) and transcardially perfused with PBS. 
 Southern blot hybridization 
 The correct insertion of the respective targeting vector into 
the SMSr locus was verifi ed by Southern blot hybridization as 
described previously ( 35 ), using genomic DNA from the liver 
 at Terkko - N
ational Library of Health Sciences, on M
ay 16, 2016
w
w
w
.jlr.org
D
ow
nloaded from
 
.html 
http://www.jlr.org/content/suppl/2015/02/09/jlr.M055269.DC1
Supplemental Material can be found at:
824 Journal of Lipid Research Volume 56, 2015
ethanolamine (PE), phosphatidylserine] scanning as described 
previously ( 41 ). The data were analyzed with Microsoft Excel us-
ing the LIMSA add-on ( 42 ). 
 To quantify CPE (and SM), a volume of the extract containing 
100 nmol of lipid phosphate was taken to dryness and dissolved in 
1.5 ml of methanol. Then 0.5 ml of chloroform/methanol (9:1 v/v) 
containing 15:0-SM (1 nmol) and 17:0-CPE (0.25 nmol) standards 
and 0.5 ml of 0.3 M NaOH were added and the samples were 
incubated overnight at room temperature. The solution was neu-
tralized by addition of 0.3 ml of 0.3 M HCl in water, and 3.5 ml of 
chloroform and 1.2 ml of water were added followed by thorough 
mixing. After centrifugation for 10 min at 3,000 rpm, the upper 
phase was removed and the lower chloroform phase was washed 
twice with 3.5 ml of theoretical Folch upper phase ( 39 ). After dry-
ing under a N 2 stream, the lipids in the lower phase were dissolved 
in 0.2 ml of methanol, moved to conical MS vials, dried and dis-
solved in 40   l of LC-MS quality methanol, and stored at   20°C. 
 The CPE and SM species were quantifi ed using LC-MS. The 
chromatographic separation was carried out in the gradient mode 
using an Acquity Ultra Performance LC system equipped with an 
Acquity BEH-C 18 1.0 × 150 mm column (Waters Inc.). The column 
temperature was 60°C and the fl ow rate 0.13 ml/min. Solvent A 
was acetonitrile/water (60:40 v/v) containing 10 mM ammo-
nium formate and 1% NH 4 OH, while solvent B consisted of 
isopropanol/acetonitrile (90:10 v/v) containing 10 mM ammo-
nium formate and 1% NH 4 OH. The gradient started from 40% B, 
changed linearly to 70% B in 10 min, and then linearly to 100% B 
in 4 min. After 2 min at 100%, B changed to 40% in 3 min and was 
kept there for 3 min prior the next injection. To detect the CPE 
and SM, the column eluent was infused to the ESI source of the 
Quattro Premier mass spectrometer operated in the positive ion 
mode using selective reaction monitoring. The CPE species were 
detected based on neutral loss of  m/z 141 and the SM species based 
on precursor ion scan/EIC of  m/z 184. The peak areas of the SM 
and CPE species and standards were obtained from the selective 
reaction monitoring chromatograms with the QuanLynx software 
(Waters Inc.) and the concentrations of the molecular species and 
the classes were determined with Microsoft Excel. 
 Electron microscopy 3 
 Wild-type and SMSrD348E mice were fi xed by perfusion via the 
left ventricle with 2.5% glutaraldehyde in 0.1 M cacodylate buffer. 
After fi xation, small pieces of tissue were incubated in 1% (w/v) 
osmium tetroxide. After rinsing in cacodylate buffer, the speci-
mens were treated with 30% and 50% ethanol followed by incuba-
tion with 1% uranyl acetate for 6 min in 70% ethanol in the dark. 
After dehydration in a graded series of ethanol and propylene 
oxide, tissues were embedded in EPON ® according to the 
manufacturer’s protocol. Ultrathin sections were obtained with a 
Reichert-Jung UltracutE ® ultramicrotome, mounted on copper 
grids and treated with 1% uranyl acetate for 20 min and 3 min with 
lead citrate (0.4%). A Zeiss transmission electron microscope (EM 
902A) was used for fi nal investigation. Digital image acquisition was 
performed using a MegaViewII slow-scan-CCD camera connected 
to a personal computer running ITEM ® 5.0 software (Soft Imaging 
Systems, Germany); images were stored as uncompressed TIFF fi les 
in 16 bits of gray and processed with Adobe ® Photoshop ® CS5. 
 Statistical analyses 
 Analyses and graphical presentation were done using Micro-
soft Excel and Graph Pad Prism 5 software (Graph Pad Software). 
Statistical signifi cance was determined by two-tailed Student’s 
Pemt +/+ and Pemt   /   mice were given free access to standard chow 
(#5001, LabDiet) ( 36 ). At 8 weeks of age, a single dose of Ad.GFP 
or Ad.PEMT (1.0 × 10 9 plaque-forming units) was injected into the 
tail vein. Seven days after injection, mice were fasted and anesthe-
tized with metofane. Tissues were dissected immediately and 
stored at   80°C. All procedures were approved by the University 
of Alberta’s Institutional Animal Care Committee in accordance 
with guidelines of the Canadian Council on Animal Care. PEMT 
activity assay was performed as described previously ( 37 ). 
 Generation of custom-made SMSr-specifi c antibodies and 
immunoblotting 
 For the generation of primary antibodies targeting the SMSr 
protein, rabbits were injected with the C-terminal peptide of the 
mouse SMSr protein (CWPFSKPAIMKRLIG) by Pineda Antibody 
Service (Berlin, Germany). Antibodies were purifi ed from the 
resulting serum by column affi nity chromatography with the 
C-terminal peptide. 
 For SMSr expression pattern analysis, tissues from wild-type and 
SMSrdelEx6 mice were homogenized in 1 ml/g wet weight of 
modifi ed RIPA buffer [50 mM Tris-HCl, 150 mM NaCl, 1 mM 
EDTA, 1 mM NaF, 1% NP-40, 0.25% Na-deoxycholate, 1 mM 
PMSF, and Complete ® protease inhibitor cocktail (Roche Applied 
Sciences, Switzerland)] using a Precellys ® homogenizer (Peqlab 
Biotechnology). Cell debris was removed by 10 min centrifugation 
at 4°C. Protein amounts were determined using a BCA assay kit. 
(Sigma-Aldrich). Depending on tissue, 25–50   g of protein in urea 
buffer [40 mM Tris-HCl, 9 M urea, 1 mM EDTA, 5% SDS, 5% (v/v) 
  -mercaptoethanol, 0.01% (w/v) bromophenol blue (pH 6–8)] 
were separated by SDS-PAGE (12%) and blotted onto nitrocellu-
lose membranes (Hybond-ECL, GE Healthcare, UK). Membranes 
were blocked for 1 h at room temperature in 5% milk powder in 
TBS-T ween. The newly generated SMSr polyclonal antibodies 
were used in a 1:1,000 dilution and incubated overnight at 4°C. 
The mouse anti-V5 antibody (Invitrogen, Germany) was used 
1:1,000 overnight at 4°C. Secondary horseradish peroxidase-
conjugated antibodies against rabbit and mouse (Dianova, 
Germany) were used 1:10,000 for 1 h at room temperature. For 
detection, Amersham ECL Prime Western blotting detection re-
agent (GE Healthcare) was used and membranes were developed 
using VersaDoc imaging system (Bio-Rad, USA). 
  -Galactosidase staining 
 Tissues of adult mice were frozen on dry ice, embedded in 
Tissue-Tek OCT and prepared for cryostat sectioning.   -
galactosidase staining was carried out according to Degen et al. 
( 38 ). Stained sections were mounted on glass slides (Menzel, 
Germany), dried on a heating plate at 37°C, and mounted with 
Entellan (Merck Millipore Chemicals, Germany). 
 Mass spectrometric analysis of lipids 
 Tissues were homogenized in a small volume of water using a 
Precellys ® homogenizer (Peqlab Biotechnology). Lipids were ex-
tracted according to Folch, Lees, and Stanley Sloane ( 39 ) with 
the standards (unnatural lipid species) added at the one-phase 
stage of extraction. After evaporation of the solvents, the lipids 
were dissolved in methanol/chloroform (2:1 v/v), the phosphate 
contents of the extracts were determined ( 40 ), and the samples 
were stored at   20°C. Glycerophospholipids and most sphingo-
lipids were analyzed using direct infusion of the samples into the 
electrospray source of a Quattro Premier triple-quadrupole mass 
spectrometer (Waters Inc., USA) operated in the MS/MS mode. 
The analytes and the internal standards were detected based on 
class-specifi c precursor ion (PC, phosphatidylinositol, ceramide, 
hexosyl- and lactosyl-ceramides) or neutral loss [phosphatidyl-  3 TEM was performed at the IMCES, University Clinics of Essen.
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PEMT caused a 20-fold increase in liver CPE levels, i.e., 
from   0.005 to 0.10 mol% of total phospholipid. Adenovi-
rus-mediated transduction of PEMT KO mice with a func-
tional PEMT construct led to a 50% reduction in liver CPE 
levels ( Fig. 1C, D ). These results indicate that PEMT may 
utilize CPE as substrate in a methylation-dependent path-
way of SM biosynthesis. As SM levels in wild-type and PEMT 
KO livers were indistinguishable and exceeded CPE levels 
at least 50-fold (data not shown), it appears that PEMT-
mediated conversion of CPE to SM makes, at best, only a 
minor contribution to the total SM pool in liver. 
 Mouse SMSr is a CPE synthase 
 Mouse SMSr shares a common domain structure with 
other SMSr homologs, which includes six transmembrane 
helices, an  N -terminal SAM domain, and a conserved active 
site comprising a catalytic triad of two histidine residues at 
positions 301 and 344, and an aspartate residue at position 
348 ( 7, 9 ). We previously showed that human and  Drosophila 
SMSr exhibit CPE synthase activity ( 24 ). To prove this also 
for mouse SMSr (mSMSr), a V5-tagged version of the pro-
tein was expressed in budding yeast, an organism lacking 
endogenous CPE synthase activity. As shown in  Fig. 2A , ly-
sates of yeast cells expressing V5 epitope-tagged mSMSr 
supported conversion of fl uorescent C6-NBD-Cer into 
NBD-CPE. In addition, expression of mSMSr-V5 in a yeast 
strain producing ceramides that structurally resemble those 
found in mammals allowed the detection of several species 
of CPE by LC-MS/MS ( Fig. 2B ). In line with our previous 
fi ndings ( 24, 26 ), substitution of the highly conserved aspar-
tate residue at position 348 for a glutamate completely abol-
ished SMSr-mediated CPE production ( Fig. 2C ). Together, 
this indicates that mSMSr is a true CPE-synthase and that 
 t -test. Differences were considered statistically signifi cant when 
 P < 0.05. 
 RESULTS 
 CPE levels in mouse tissues are exceedingly low 
 To support the functional analysis of SMSr in mice, we 
fi rst quantifi ed CPE levels in a variety of mouse tissues (i.e., 
forebrain, cerebellum, liver, testis, kidney, spleen, lung, 
heart, muscle, and small intestine). Because we were unable 
to detect CPE by direct infusion MS/MS, CPE levels were 
determined by LC-MS analysis and directly compared with 
SM levels. This revealed that in all tissues examined, the 
steady-state levels of CPE were exceedingly low, i.e., 300- to 
1,500-fold lower than SM levels, depending on the tissue 
analyzed ( Fig. 1A, B ). The highest levels of CPE (  0.020 
mol% of total phospholipid) were observed in testis and 
brain, whereas CPE levels in heart and liver were particu-
larly low (  0.002–0.005 mol% of total phospholipid). 
These results are consistent with the low abundance of CPE 
in a variety of mammalian cell lines ( 24 ). 
 CPE in liver is a putative substrate for PEMT-mediated 
SM production 
 SM biosynthesis in mammals mainly occurs through SM 
synthase-mediated headgroup transfer from PC to ceramide 
( 9 ). However, an alternative pathway of SM production has 
been postulated in liver, which involves the step-wise meth-
ylation of CPE ( 21, 43 ). This reaction is analogous to the  S -
adenosylmethionine-dependent conversion of PE to PC 
catalyzed by the liver-specifi c enzyme PEMT ( 36, 37 ). To 
investigate whether PEMT contributes to the exceedingly 
low CPE content in liver, we analyzed the impact of PEMT 
removal on liver CPE levels. As shown in  Fig. 1C , deletion of 
 Fig.  1. CPE and SM levels in different mouse tis-
sues. A, B: LC-MS analysis of CPE and SM levels in 
forebrain, cerebellum, liver, testis, kidney, spleen, 
lung, heart, muscle, and small intestine (s. intestine) 
of wild-type mice (n = 4). C: LC-MS analysis of liver 
CPE content in wild-type (WT) mice, PEMT KO mice 
transduced with GFP (KO Ad. GFP), and PEMT KO 
mice transduced with functional PEMT (KO Ad. 
PEMT) (n = 2–3). D: PEMT activity assay from liver 
lysates of wild-type mice transduced with GFP (WT 
Ad. GFP), PEMT KO mice transduced with GFP (KO 
Ad. GFP), and PEMT KO mice transduced with func-
tional PEMT (KO Ad. PEMT) (n = 3). Data are means 
± SEM; ** P < 0.005,  *** P < 0.001. 
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genotypes were confi rmed by PCR genotyping ( Fig. 3B ; 
supplementary Fig. 1B) and Southern blot hybridization 
( Fig. 3D ; supplementary Fig. 1C). In the case of the 
SMSrD348E mice, an additional  Mfe I digestion confi rmed 
the D348E point mutation ( Fig. 3C ). Offspring from mat-
ings with heterozygous mice were born at the expected 
Mendelian ratio for both mouse lines, indicating a nones-
sential role of SMSr during embryogenesis. 
 Mouse smsr is a widely expressed gene 
 SMSrD348E mice express the   -galactosidase reporter pro-
tein with a nuclear localization signal under the control of 
the endogenous  smsr promoter ( Fig. 3A ). As there are essen-
tially no data available regarding the tissue- and cell type-
specifi c expression of SMSr, we analyzed the   -galactosidase 
expression in different tissues of the SMSrD348E mice ( Fig. 
4 ), using tissues from wild-type mice as controls (data not 
shown). We detected   -galactosidase staining in brain neuro-
nal areas such as the forebrain cortex, the dentate gyrus, and 
the hippocampal regions CA1, CA2, CA3, and CA4, as well as 
the cerebellar and the granular cell layer ( Fig. 4A, B ). In tes-
tis, we detected staining signals adjacent to the basal epithe-
lium of the seminiferous tubules indicating nuclear staining 
of spermatogonia ( Fig. 4C ). Furthermore, we detected   -
galactosidase expression throughout the pancreas, with a 
the SMSrD348E point mutation leads to catalytic inactiva-
tion of the enzyme. 
 Generation of SMSrD348E and SMSrdelEx6 mice 
 The mouse  smsr gene is located on chromosome 14 and 
includes six exons. To study the biological functions of 
SMSr in mice, two transgenic mouse lines were generated 
expressing the SMSrD348E point mutation (SMSrD348E; 
 Fig. 3 ) or a transcript lacking exon 6 of the  smsr gene, in-
cluding sequences for histidine residue 344 and aspartate 
residue 348 (SMSrdelEx6; supplementary Fig. 1). The 
SMSrD348E mice express a LacZ reporter protein and the 
SMSrdelEx6 mice express a SMSr NT -eGFP fusion protein 
( Fig. 3A ; supplementary Figs. 1A, 5A) under transcrip-
tional control of the endogenous SMSr promoter . Thus 
both should represent the expression of SMSr. For inacti-
vation of the mouse  smsr gene, we used the nonconditional 
SMSrD348E or the conditional SMSrdelEx6 vector (for 
details see Materials and Methods). 
 SMSrD348E and SMSrdelEx6 mice are viable and fertile 
 Heterozygous animals without the neomycin selection 
cassette were bred to generate homozygous SMSrD348E 
or a SMSrdelEx6 mice, respectively. Homozygous mice of 
both mouse lines were viable and fertile. The different 
 Fig.  2. Mouse SMSr catalyzes CPE production. A: 
TLC separation of reaction products obtained when 
NBD-Cer was incubated with lysates of yeast strains ex-
pressing hSMSr or mSMSr . Part of the TLC (control 
and hSMSr) was already published ( 24 ), but is illus-
trated here for immediate comparison. B: Different 
molecular species of CPE detected by LC-MS/MS anal-
ysis (neutral loss of 141) after alkaline hydrolysis of 
glycerolipids in SMSr-expressing Conzelmann yeast 
strain in which endogenous ceramide synthases were 
substituted for mouse ceramide synthase 5; see ( 24 ) 
for further details. C: TLC separation of reaction prod-
ucts obtained when NBD-Cer was incubated with ly-
sates of yeast strains expressing hSMSr or hSMSrD348E 
proving missing catalytic activity of the point mutated 
protein. Immunoblot analysis (below TLC) confi rms 
that equal amounts of protein were used. hSMSr, hu-
man SMSr; mSMSr, mouse SMSr. 
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Ceramide phosphoethanolamine biosynthesis in mice 827
were subjected to immunoblot analysis. As the SMSr NT -
eGFP fusion protein produced in SMSrdelEx6 mice lacks 
the C terminus of native SMSr, tissue samples from these 
mice served as control for the specifi city of the anti-SMSr 
antibodies. In tissues from wild-type mice, a protein migrat-
ing at approximately 42 kDa was found to cross-react with 
the anti-SMSr antibodies. This protein was consistently ab-
sent from tissues of SMSrdelEx6 mice ( Fig. 5C, D ) and its 
estimated molecular mass is close to that of the 415-residue 
protein encoded by the mouse  smsr gene. Therefore, we 
here refer to the 42 kDa protein as SMSr. In line with the 
  -galactosidase expression and microarray data, SMSr shows 
a broad tissue distribution, with the strongest expression in 
testis, brain, kidney, and pancreas. SMSr was also expressed 
in embryonic fi broblasts and bone marrow-derived macro-
phages (data not shown). An additional immuno-reactive 
protein, at approximately 48 kDa, was found in a subset 
of tissues from wild-type mice, but not in those from 
SMSrdelEx6 mice. This protein, which we here refer to as 
SMSr-2, was particularly abundant in testis ( Fig. 5C ). In line 
with these fi ndings, database analysis revealed two distinct 
mouse  smsr transcripts, one coding for the 415-residue pro-
tein (SMSr) and the other one coding for a 478-residue pro-
tein (Ensembl gene identifi cation: ENSMUSG00000021770 ). 
Expression of the 478-residue protein, which likely corre-
sponds to SMSr-2, is predicted to result from alternative 
splicing, which creates an alternative start codon in exon 1. 
The predominance of SMSr-2 over SMSr in testis might 
prominent staining of the exocrine portion and a some-
what weaker staining of the endocrine   -islets ( Fig. 4D ). In 
kidney, we found  smsr promoter activity predominantly 
in the cortex ( Fig. 4E ), whereas the medulla and papilla 
were devoid of   -galactosidase staining (data not shown). 
Cardiomyocytes of the myocard showed weak nuclear 
staining, but the  smsr promoter activity in the atrioventric-
ular node was more pronounced ( Fig. 4F ). In liver,   -
galactosidase staining was observed throughout the whole 
tissue, but the staining was not homogenous, e.g., with 
stronger signals in the regions surrounding portal fi elds 
( Fig. 4G ; data not shown). The results suggest a broad tis-
sue distribution of  smsr transcripts in mice. Moreover, mi-
croarray experiments revealed that  smsr transcripts are 
relatively evenly expressed in mouse tissues, especially in 
comparison to  sms1 and  sms2 transcripts ( Fig. 4H ). 
 Tissue-specifi c distribution of SMSr protein 
 To complement our analysis of  smsr expression in mice, 
we raised polyclonal antibodies against a peptide corre-
sponding to the C terminus of SMSr, which is conserved 
between the mouse and human protein (CDGPIPDLSS-
DQYQY;  Fig. 5A ). The antibodies cross-reacted with a pro-
tein migrating at approximately 42 kDa in lysates of yeast 
cells expressing V5-tagged human SMSr; this protein was 
absent in control cells ( Fig. 5B ). To determine the tissue-
specifi c expression of SMSr in mice, total protein extracts of 
19 different tissues from wild-type and SMSrdelEx6 mice 
 Fig.  3. Generation of SMSrD348E mice. A: Scheme of homologous recombination for generation of SMSrD348E mice. B: Genotyping 
PCR for wild-type (+/+), heterozygous (+/SMSrD348E), and homozygous (SMSrD348E) mice; characteristic DNA fragments 393 bp (wild-
type), 493 bp (D348E), 580 bp (Neo; mice with neomycin selection cassette). C: The sequence exchange leading to the SMSrD348E point 
mutation additionally produced an  Mfe I restriction site. This was validated by  Mfe I digestion of a 433 bp PCR amplicon generated from the 
D348E allele. The fragments of 320 bp and 113 bp after  Mfe I treatment confi rm the identity of the point mutation. D: Southern blot analysis 
of SMSrD348E mice. Expected fragment sizes:  Bcl I restriction, wild-type 12.2 kbp; D348E 13.8 kbp. 
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CPE-synthase activity was determined by incubating liver 
and brain microsomal preparations with NBD-Cer and ana-
lyzing the reaction products by TLC. As shown in  Fig. 6A , 
incubation of NBD-Cer with brain microsomes from wild-
type mice resulted in the formation of NBD-CPE, NBD-SM, 
and NBD-glucosylceramide (NBD-GlcCer). Formation of 
NBD-CPE was essentially abolished when NBD-Cer was in-
cubated with microsomes from SMSrD348E or SMSrdelEx6 
mice, while the production of NBD-SM and NBD-GlcCer 
was not affected. In brain microsomes from SMS2gt 
mice, on the other hand, the formation of NBD-SM was 
therefore be a consequence of the fact that alternative splic-
ing is particularly prevalent in this tissue ( 44 ). 
 SMSr is the principal CPE synthase in brain 
 We next analyzed the impact of catalytic inactivation of 
SMSr on CPE synthase activity in mouse brain and liver, 
i.e., tissues in which this activity was fi rst described ( 21 ). 
Because SMS2 is known to have dual activity as CPE syn-
thase ( 23 ), we crossed the SMSr mutant mice with SMS2gt 
mice ( 27 ) and bred double mutants to determine the rela-
tive contribution of each enzyme to CPE biosynthesis. 
 Fig.  4. Mouse  smsr is a ubiquitously expressed gene.   -galactosidase staining of cryo-sections from various SMSrD348E mouse tissues 
(A–G) correlates with  smsr promoter activity. Neuronal regions of allo- and neocortical brain areas (A) and cerebellum (B) show prominent 
  -galactosidase staining mainly of nuclei and perinuclear areas of neurons. In testis, spermatogonia in the basal epithelium of the seminif-
erous tubules show similar nuclear   -galactosidase staining (C). In pancreas,   -galactosidase expression is displayed throughout the whole 
tissue, with a prominent staining of the exocrine portion and a somewhat weaker staining of the endocrine   -islets (D). In kidney, promi-
nent   -galactosidase staining is displayed in the tubular system of the cortex (E). In heart, nuclei of all cardiomyocytes are   -galactosidase 
positive, especially those of the atrioventricular node (F). In liver, the distribution of   -galactosidase activity is diffuse with areas of more 
and others of less intensive staining that cannot be clearly associated to special regions of the hepatic lobules (G). AV, atrioventricular node; 
Cx, cortex; DG, dentate gyrus; EC, exocrine cells; GC, granular cell layer; HC, hippocampus; L, islets of Langerhans; P, portal fi eld; PC, 
Purkinje cell layer; S, seminiferous tubule. H: Transcript expression profi les from microarray analysis of SMSr (Samd8), SMS2 (Sgms2), and 
SMS1 (Sgms1), modifi ed according to BioGPS ( 47 ), data set Mouse MOE430 Gene Atlas ( 48 ). Microarray data were generated using an 
Affymetrix Mouse Genome 430 2.0 Array (GEO platform accession number GPL1261). 
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Forebrain and cerebellum of SMSrD348E and the double 
mutant mice displayed a 40–60% reduction in short-chain 
CPE species (C18:0, C20:0) relative to wild-type mice ( Fig. 
7A, B ), consistent with SMSr being a major CPE synthase in 
brain ( Fig. 6A ). SMSr inactivation had, if any, only a minor 
impact on long-chain CPE levels (C22:0, C24:0, C24:1) and 
did not infl uence SM levels ( Fig. 7D, E ). In contrast, deletion 
of SMS2 did not affect CPE levels in these tissues, but caused 
a minor (up to 20%) reduction in SM levels, in line with its 
impact on brain-associated SM synthase activity ( Fig. 6A ). 
 We were unable to detect signifi cant differences between 
CPE levels in liver from wild-type, SMSrD348E, and double 
mutant mice ( Fig. 7C ), even though a combined inactiva-
tion of SMSr and SMS2 essentially abolished liver-associated 
CPE synthase activity ( Fig. 6A ). However, a reliable quantifi -
cation of CPE species in liver is complicated by the fact that 
their levels are barely detectable, presumably due to meta-
bolic conversion of CPE by liver-specifi c PEMT ( Fig. 1C, D ). 
Removal of SMS2 resulted in a signifi cant decrease in liver 
SM levels ( Fig. 7C ), in line with SMS2 corresponding to the 
major SM synthase activity in this tissue ( Fig. 6B ). 
strongly diminished while NBD-CPE production was 
largely unaffected. These results indicate that SMSr oper-
ates as the principal CPE synthase in brain. In liver micro-
somes of wild-type mice, NBD-Cer was also converted into 
NBD-CPE, NBD-SM, and NBD-GlcCer ( Fig. 6B ). Forma-
tion of NBD-SM was unaffected by catalytic inactivation of 
SMSr, but almost completely abolished in liver microsomes 
from SMS2gt mice. Formation of NBD-CPE, on the other 
hand, was only slightly reduced in liver microsomes from 
SMSrD348E, SMSrdelEx6, and SMS2gt mice. However, 
NBD-CPE production was completely wiped out in liver 
microsomes from the double mutants ( Fig. 6B ). From this 
we conclude that in mouse liver, both SMSr and SMS2 con-
tribute signifi cantly to CPE biosynthesis. 
 Impact of SMSr inactivation on tissue CPE levels 
 We next analyzed the impact of disrupting SMSr catalytic 
activity on CPE levels in various mouse tissues, including 
brain and liver. To this end, we used LC-MS to quantify indi-
vidual CPE species in tissues from wild-type, SMSrD348E, 
SMS2gt, and SMSrD348E×SMS2gt double mutant mice. 
 Fig.  5. Tissue-specifi c expression of SMSr protein in mice. A: Predicted membrane topology of wild-type SMSr, SMSrD348E, and SMSr NT -
eGFP fusion protein produced in SMSrdelEx6 mice. The eGFP reporter replaces the endogenous C terminus in the SMSr NT -eGFP (SMSrdelEx6) 
fusion protein and is predicted to be oriented toward the ER lumen. Lack of the C terminus allowed validating specifi city of newly generated 
antibodies targeting the C terminus in immunoblot analysis (B–D). Sizes: Wild-type and SMSrD348E, 48.2 kDa (415 aa); SMSr NT -eGFP 
(SMSrdelEx6), 63.5 kDa (559 aa). B: Immunoblot analysis with lysates from yeast cells overexpressing an hSMSr-V5 vector confi rmed specifi c-
ity of the generated antibodies . The 49.6 kDa SMSr-V5 fusion protein was recognized by the SMSr antibodies, as well as by an antibody target-
ing the V5-tag. Ponceau S staining was used as loading control. C, D: Immunoblot analysis of wild-type tissues. Lysates from SMSrdelEx6 mice 
served as negative control and further confi rmed specifi city of the antibodies. Besides the 48.2 kDa SMSr protein, the antibodies recognize the 
predicted 54.7 kDa SMSr-2 isoform. Both isoforms did not migrate to positions expected for their theoretical mass. Using different protein 
standards, we show that SMSr and the corresponding SMSr-V5 are detected at about 42 kDa, whereas SMSr-2 was detected at about 48 kDa. 
GAPDH was used as loading control. Note: 25   g of protein were applied for forebrain, cerebellum, and testis, 50   g for liver and other tissues. 
(Data are representative of at least three independent experiments; s., small; l., large). hSMSr, human SMSr. 
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minor extent to the CPE content of the testis, kidney, 
spleen, and lung. Curiously, combined inactivation of 
SMSr and SMS2 did not eliminate CPE in any of the tissues 
examined. This implies that mammals are equipped with 
CPE synthase(s) other than SMSr and SMS2. The identity 
of these enzyme(s) remains to be established. 
 SMSr inactivation does not affect ceramide and 
hexosylceramide levels in mouse tissues 
 Acute depletion or catalytic inactivation of SMSr in hu-
man HeLa or  Drosophila S2 cells causes a substantial rise in 
ER ceramide and hexosylceramide levels ( 24 ). Unexpect-
edly, none of the tissues of SMSrD348E mutant mice 
displayed any increase in ceramide or hexosylceramide 
content when compared with wild-type ( Fig. 7 ; supplemen-
tary Fig. 7), not even in brain, where SMSr inactivation es-
sentially abolished CPE synthase activity ( Fig. 6A ). In the 
kidney, spleen, lung, and heart of SMS2gt×SMSrD348E mu-
tant mice, we detected a minor increase in ceramide and 
 Further analysis revealed only a minor decrease in the lev-
els of short-chain CPE species in testis, kidney, spleen, and 
lung of SMSrD348E mutant mice (supplementary Fig. 2). In 
the small intestine, a signifi cant decrease was only observed 
for the double mutant (supplementary Figs. 2, 6), indicating 
that both SMSr and SMS2 contribute to the total CPE levels 
in this tissue. In heart and muscle, on the other hand, we 
could not detect any signifi cant difference in CPE levels be-
tween wild-type, SMSrD348E, and double mutant mice (sup-
plementary Figs. 2, 6). Removal of SMS2 caused a signifi cant 
reduction in SM levels in kidney (supplementary Fig. 3), a 
tissue where this enzyme is well-expressed ( Fig. 4H ). Quanti-
tative MS/MS analysis of the various glycerophospholipid 
classes revealed no obvious changes between tissues of wild-
type and mutant mice, except for a minor increase in the 
overall levels of PE and phosphatidylserine in the spleen and 
heart of the mutants (supplementary Fig. 8). 
 In sum, these results indicate that SMSr signifi cantly 
contributes to the CPE pool in the brain, and only to a 
 Fig.  6. Impact of SMSr and SMS2 inactivation on 
CPE and SMS activity in mouse liver and brain. A, B: 
TLC separation of reaction products formed after in-
cubation of liver and brain microsomal preparations 
with NBD-Cer. NBD-CPE production in brain is com-
pletely abrogated in SMSrD348E and SMSrdelEx6 
single mutants, but not in SMS2gt microsomes (A). In 
contrast, in the liver, production of NBD-CPE is only 
reduced in single mutants and not detectable in 
SMS2gt×SMSrD348E and SMS2gt×SMSrdelEx6 dou-
ble mutants (B). (Data are representative of at least 
two independent experiments). 
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of ER exit sites, a structural collapse of the Golgi complex, 
and induction of mitochondrial apoptosis, which can be 
reverted by blocking de novo ceramide synthesis ( 24, 26 ). 
This led us to analyze liver and brain cells from SMSrD348E 
mice for ultrastructural aberrations in their secretory ap-
paratus. We did not observe any obvious deviations in 
Golgi or ER morphology in hepatocytes from SMSrD348E 
mice when compared with their wild-type littermates ( Fig. 
8A, B ). In addition, the integrity of mitochondria was not 
altered and we could not detect any difference in appear-
ance or number of lipid droplets or glycogen granules. We 
also found no signifi cant changes in the serum activities of 
liver transaminases and creatine phosphokinase between 
wild-type and SMSrD348E mutant mice (supplementary 
Fig. 9), indicating that catalytic inactivation of SMSr does 
not compromise the overall integrity of liver cells. A sys-
tematic analysis of neuronal cells in different regions of 
the brain in SMSrD348E mice also did not reveal any sig-
nifi cant alterations in cellular integrity relative to wild-
type mice ( Fig. 8C, D ). It therefore appears that cells of 
hexosylceramide levels (supplementary Fig. 7). For the kid-
ney, this could be a direct consequence of a block in SMS2-
mediated SM production, as the accumulation of ceramides 
and hexosylceramides in this tissue was accompanied by a 
signifi cant drop in SM levels (supplementary Fig. 6). Be-
sides the species with incorporated sphingosine (d18:1), we 
also investigated the sphinganine (d18:0)- and sphinga-
diene (d18:2)-based species of ceramide, hexosylceramide, 
and SM, as well as species with hydroxylated and odd-
numbered fatty acyl-chains and free long-chain bases (d18:0, 
d18:1, and d18:2) in liver and brain. In all cases, we did not 
fi nd any signifi cant differences in the levels of these species 
between wild-type and SMSrD348E mutant mice (data not 
shown). From this, we conclude that SMSr does not seem to 
operate as a critical regulator of ceramide levels in mice. 
 Disruption of SMSr catalytic activity has no impact on the 
structural integrity of mouse brain or liver cells 
 The rise in ER ceramides caused by an acute depletion 
of SMSr in cultured animal cells results in a fragmentation 
 Fig.  7. LC-MS analysis of CPE, SM, ceramide, and hexoyslceramide species in forebrain, cerebellum, and liver of wild-type, SMSrD348E, 
SMS2gt×SMSrD348E, and SMS2gt mice. A–C: Analysis of main CPE species. D, E: Analysis of main SM species. F–H: Analysis of main ceramide 
species. I–K: Analysis of main hexosylceramide (Hex-Cer) species. Data are means ± SEM; * P < 0.05, ** P < 0.005, *** P < 0.001; n = 3–4. 
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 The present analyses of enzyme activities in the brain 
and liver of SMS mutant mice complements our previous 
heterologous expression studies ( 23, 24 ), and now fi rmly 
establishes SMSr as monofunctional CPE synthase and 
SMS2 as a bifunctional enzyme with both SM and CPE syn-
thase activity. In line with our previous fi ndings in cultured 
mammalian cells ( 24 ), both enzymes seem to produce 
only trace amounts of CPE in mouse tissues, with steady 
state levels   300- to 1,500-fold below those of SM. Meta-
bolic labeling experiments in cultured HeLa cells indi-
cated that CPE is not a short-lived metabolic intermediate 
( 24 ). However, our present data suggest that in liver cells, 
CPE may be used as precursor in a methylation-dependent 
pathway of SM production by the liver-specifi c methyl-
transferase, PEMT. In fact, this could explain why steady-
state CPE levels in the liver are particularly low in 
comparison to other tissues, in spite of expressing both 
SMSr and SMS2. While PEMT-catalyzed methylation of 
SMSrD348E mutant mice in general are devoid of pheno-
types associated with a deregulation of ER ceramides. 
 DISCUSSION 
 SMSr is a highly conserved member of the SMS family 
that, along with its relative SMS2, catalyzes production of 
the SM analog CPE. Studies in cultured cells previously 
revealed a critical role of SMSr in ceramide homeostasis 
and as suppressor of ceramide-induced mitochondrial 
apoptosis. We now show that ubiquitous catalytic inactiva-
tion of SMSr in mice primarily disrupts CPE biosynthesis 
in the brain without having any obvious impact on steady 
state ceramide levels, cell integrity, or survival. Besides 
pointing at a discrepancy between the in vitro and in vivo 
function of SMSr, our study provides a fi rst inventory of 
CPE levels and CPE-biosynthetic enzymes in mammals. 
 Fig.  8. Electron micrographs of hepatocytes and hippocampal neurons of wild-type and SMSrD348E mice. A: Wild-type mice reveal the 
typical cellular equipment of liver cells with abundant rough ER (RER), numerous mitochondria (Mi), lipid droplets (L), and large glyco-
gen stores (Gs). Higher magnifi cation of a small Golgi-apparatus, which is typical for liver cells, shows big vesicles containing lipoprotein 
complexes (insert). B: There are no obvious morphological differences detectable in cell organelles of a SMSrD348E hepatocyte. Higher 
magnifi cation of a comparable Golgi-complex does show the same appearance with large vesicles containing lipoproteins (insert). C: Hip-
pocampal neurons of wild-type mice revealed the typical morphology with abundant free ribosomes, mitochondria, and some Golgi-com-
plexes. D: No obvious alterations in the morphology of cell organelles were observed in comparable SMSrD348E neurons. For analysis, 
littermates were used (n = 4). N, nucleus; Nc, nucleolus; b, bile canaliculus; G, Golgi-apparatus, L, lipid droplet; Gs, glycogen stores; GV, 
Golgi vesicle; Mi, mitochondria; #, Nissl substance; NP, nuclear pores; scale bar insert, 200 nm. 
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alter ceramide levels, cell survival, or integrity in any of the 
tissues examined came as a surprise. How can these two 
contradictory outcomes be reconciled? 
 A fi rst point to consider is that the experiments with cul-
tured cells focused on the short-term consequences of 
SMSr inactivation, i.e., within 3 days after siRNA-mediated 
depletion of the endogenous protein and its exchange for a 
siRNA-resistant catalytically inactive protein (SMSrD348E). 
This time span might be too short for some cells to adapt 
their metabolic activity toward normalizing ER ceramide 
levels before any perturbation of cell integrity and viability 
occurs. Because we analyzed adult mice, we cannot rule 
out that the SMSrD348E mutation causes a transient de-
regulation of ER ceramides in an early stage of develop-
ment that individual embryonic cells are able to overcome. 
Ceramides serve as “metabolic hub” and cells are equipped 
with a multitude of enzymes to modulate their levels. This 
may explain why genetic ablation of SMS1 and SMS2 in 
mice causes only a modest increase in tissue ceramide lev-
els [( 13, 15, 27 ), and this study], even though these en-
zymes normally consume the bulk of newly synthesized 
ceramides ( 10 ). As tissues of SMSrD348E mutant mice did 
not contain any signifi cantly elevated levels of sphingoid 
bases, hexosylceramides, or SM, it is unclear how embry-
onic cells with disrupted SMSr catalytic activity were able 
to overcome a deregulation of ER ceramides associated 
with a disruption in SMSr catalytic activity. One approach 
to investigate short-term effects of SMSr inactivation and 
explore compensatory mechanisms in vivo could be to 
crossbreed the conditional SMSrdelEx6 mice described in 
this study with mice expressing an inducible Cre recombi-
nase ( 46 ). The presence of a functional SAM domain in 
SMSrD348E and SMSrdelEx6 mice might also explain why 
ceramide levels and cellular integrity are not altered, be-
cause this domain, similar to catalytic activity, proved to be 
essential in preventing ceramide accumulation and apo-
ptosis in cultured HeLa cells ( 24, 26 ). Finally, we cannot 
rule out the existence of a protein with redundant func-
tion that copes with the consequences of SMSr inactiva-
tion. Loss of this protein in a genetically unstable cancer cell 
line such as HeLa would provide an alternative explanation 
for the discrepancy between data collected from cell lines 
and the mouse model. 
 In summary, our data indicate that SMSr does not qualify 
as an essential regulator of ceramide levels in mice kept un-
der standardized conditions. While SMSr is a CPE synthase 
with homologs found throughout the animal kingdom, we 
fi nd that SMSr-catalyzed CPE production is dispensable for 
mouse development, survival, and healthiness. This does 
not rule out a critical role of SMSr under stressed metabolic 
conditions. Therefore, challenging SMSrD348E mutant 
mice with infl ammatory stimuli, altered diet conditions, or 
drugs that interfere with ceramide metabolism might shed 
further light on its in vivo function.  
 The authors thank Prof. Maarten Egmond (University of 
Utrecht) for synthesis and purifi cation of SMSr immunogenic 
peptides, Brita Wilhelm (Bonn) and Susanne Lingrell (Helsinki) 
for technical assistance, as well as Christine Siegmund (Bonn) 
CPE remains to be verifi ed in enzyme assays, our results 
indicate that the contribution of the PEMT-dependent 
pathway to the total liver-associated SM pool is at best very 
small and its physiological relevance is unclear. 
 All SMS enzymes utilize a lipid phosphate phosphatase-
type reaction mechanism, involving a single lipid binding 
site and proceeding via transfer of the headgroup from PC 
or PE to a conserved histidine in the enzyme’s active site 
( 9 ). When diacylglycerol is replaced by ceramide, the 
headgroup is transferred onto ceramide to generate SM or 
CPE, respectively . Why SMSr and SMS2 are intrinsically 
unable to produce bulk amounts of CPE is not known. 
The ability of SMS2 to produce large amounts of SM could 
be due to the enzyme having a higher affi nity for PC than 
PE as headgroup donor in the transfer reaction or, alter-
natively, because of a high PC/PE ratio in the exoplasmic 
leafl et of the plasma membrane where its active site re-
sides ( 7, 10 ). Another possibility is that catalytic activity of 
SMS2 and SMSr is under negative control by their prod-
uct, CPE. In any case, bulk production of CPE in insects is 
catalyzed by an entirely different enzyme that belongs to 
an insect-specifi c branch of the CDP-alcohol transferase 
superfamily ( 25 ). This implies that the reaction mecha-
nism used by SMS family members is unsuited for effi cient 
production of CPE. 
 Remarkably, combined inactivation of SMSr and SMS2 
signifi cantly reduced, but did not eliminate, CPE levels in 
any of the mouse tissues examined. At present, we cannot 
rule out that residual CPE levels originate from the diet. 
Alternatively, enzymes other than SMSr and SMS2 might 
contribute to CPE production. For instance, enzymes that 
utilize ethanolamine in a headgroup transfer reaction 
with SM could help sustain the CPE pool. We recently no-
ticed that Golgi-resident SM synthase SMS1 produces min-
ute amounts of CPE, and that only a few substitutions of 
residues near the active site are needed to convert the en-
zyme into a monofunctional CPE synthase (M. Kol and 
J. C. M. Holthuis, unpublished observations). Therefore, 
our fi nding that combinatorial loss of SMSr and SMS2 has 
no impact on CPE levels in testis could be due to the rela-
tively high expression of SMS1 in this tissue. Knowing the 
origin of the SMSr/SMS2-independent CPE pool should 
facilitate future studies on the biological role of this enig-
matic sphingolipid in mammals. 
 We previously showed that acute disruption of SMSr cata-
lytic activity in human HeLa or  Drosophila S2 cells causes an 
accumulation of ER ceramides, a structural collapse of ER 
exit sites, Golgi fragmentation, and induction of a mito-
chondrial pathway of apoptosis ( 24, 26 ). Another study with 
cultured HeLa cells suggested that the accumulation of ce-
ramides upon SMSr depletion is not due to an increased de 
novo synthesis ( 45 ). Nevertheless, the compromised struc-
tural integrity and viability of acutely SMSr-depleted cells 
could be suppressed by blocking de novo ceramide synthe-
sis, stimulating ceramide export from the ER, or consuming 
excess ceramides by targeting SMS1 to the ER, indicating 
that these phenotypes are primarily due to a deregulation 
of ER ceramides ( 24, 26 ). Therefore, our present fi nding that 
catalytic inactivation of SMSr in mice does not signifi cantly 
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